Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth

Area of Science:

• Immunology
• Vaccinology
• Pediatrics

Background:

• Childhood hepatitis B vaccination is crucial for long-term public health.
• Assessing the durability of vaccine-induced immunity in children is essential for understanding long-term protection.
• Persistence of anti-hepatitis B-S antigen antibody (anti-HBs) levels is a key indicator of vaccine effectiveness.

Purpose of the Study:

• To evaluate the persistence of anti-HBs antibodies in children 10-11 years after primary hepatitis B vaccination.
• To assess the immunogenicity of different hepatitis B vaccine booster doses in non-seroprotected children.

Main Methods:

• Longitudinal study of 453 healthy children vaccinated at birth.
• Measurement of anti-HBs antibody titers at 10-11 years of age.
• Administration of varying doses of hepatitis B vaccine booster and assessment of antibody responses.

Main Results:

• Nearly 42% of children lacked protective anti-HBs antibody titers at 10-11 years of age.
• A significant majority (87.3%) of children receiving a booster dose achieved protective anti-HBs titers (≥10 IU/L).
• Booster vaccination rapidly restored protective antibody levels, demonstrating robust immunologic memory.

Conclusions:

• Hepatitis B vaccine-induced immunity may wane in a substantial proportion of children by adolescence.
• Booster vaccination is highly effective in re-establishing protective immunity against hepatitis B.
• The findings support the importance of monitoring vaccine-induced immunity and considering booster strategies if necessary.